U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07828470) titled 'A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of KL0011034 Injection Administered by Continuous Infusion in Healthy Adult Subjects' on Sept. 11.
Brief Summary: This study is a randomized, double-blind, propofol position-controlled trial, evaluating the safety, tolerability, and pharmacodynamic of continuous infusion of KL0011034 injection compared with propofol injectable emulsion for durations of 1 hour, 2 hours, and 3 hours, and evaluating the pharmacokinetic of the KL0011034 injection.
Study Start Date: Oct. 13
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
DRUG: KL0011034 i...